Medicai, a cloud-native medical imaging platform, took center stage at the Romanian Digital Day held at the European Parliament on June 30, 2026. Co-founder Andrei Blaj participated in a panel on research and innovation, co-organized by ANIS, the Romanian software and services industry association, and Innovation Labs at the Polytechnic University of Bucharest. The panel brought together Romanian technology leaders to discuss how Europe can transform its tech potential into competitive growth, focusing on research, academia-industry collaboration, public policy, and the adoption of private-sector innovation in public systems.
Blaj highlighted the productivity impact of AI in healthcare and the challenge of integrating private innovation into the public sector. He described how Medicai, a top PACS and patient intake software, is reducing one of the most time-consuming tasks clinicians face: making sense of fragmented patient records. Using a common oncology scenario, Blaj illustrated how a patient arriving at a public hospital with a printed file of roughly 100 pages requires a doctor or resident to read the entire document to reconstruct the patient’s history. With Medicai, that file is scanned at reception, organized chronologically, labeled by document type—such as imaging report, biopsy, or immunohistochemistry report—and enriched with key extracted information, including diagnosis, staging, treatments administered, and medical history.
The feature, introduced four months ago, is now in use at 10 hospitals, processing thousands of patient files each month. In one reported case, a physician estimated that Medicai saved roughly five hours of manual review work for a single patient. “Today, a doctor often has to read a hundred pages and rebuild a patient’s history by hand. We turn that into minutes, so clinicians get that time back for care,” said Andrei Blaj. “That is exactly the conversation Europe needs about bringing private innovation into public healthcare, and it is why being on this panel mattered to us.”
Medicai currently serves more than 100 healthcare organizations across the EU and the US and supports care for over 3 million patients, with a focus on imaging-heavy specialties including oncology, neurology, orthopedics, and radiology. The panel was opened by Corina Vasile, Executive Director of ANIS, and Razvan Rughinis, Co-founder of Innovation Labs. Discussions centered on how research, academia-industry collaboration, and public policy can help build a more competitive European technology sector.
The implications of Medicai’s presentation are significant for healthcare leaders and policymakers. By demonstrating a tangible reduction in administrative burden, the platform offers a blueprint for integrating AI into public health systems, potentially improving clinician efficiency and patient outcomes. For the industry, this signals a growing trend where private innovation addresses critical bottlenecks in public healthcare, urging stakeholders to reconsider procurement and adoption policies. As Europe seeks to boost its tech competitiveness, Medicai’s example highlights the value of supporting startups that bridge the gap between research and real-world application.
